Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...

MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...

Optimizing use of topical agents begins with defining "mild or moderate." Clinical trials in psoriasis employ objective ...

The topical treatment had no significant effect on total or central corneal fluorescence staining score.

MIAMI, FL / ACCESS Newswire / March 13, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on ...

Bacterial vaginosis affects nearly 1 in 3 women of reproductive age. A study adds to evidence it is sexually transmitted, ...

Treatment-emergent adverse events (TEAEs) occurred in a similar proportion of patients in each group, and were mostly mild or ...

MIRA Pharmaceuticals (MIRA) announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain.

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...